Faron Pharmaceuticals Oy (HEL:FARON)
Finland · Delayed Price · Currency is EUR 1.882
-0.056 (-2.89%)
At close: Dec 19, 2025
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of €214.5 million as of December 19, 2025. Its market cap has decreased by -5.77% in one year.
Market Cap
214.50M
Enterprise Value
223.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.88
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 76.45M to 214.50M, an increase of 180.59%. That is a compound annual growth rate of 10.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 214.50M | -17.29% |
| Dec 31, 2024 | 259.36M | 7.28% |
| Dec 29, 2023 | 241.77M | 19.52% |
| Dec 30, 2022 | 202.28M | 19.31% |
| Dec 31, 2021 | 169.54M | 24.58% |
| Dec 31, 2020 | 136.09M | 1.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orion Oyj | 8.64B |
| Terveystalo Oyj | 1.19B |
| Revenio Group Oyj | 599.90M |
| Pihlajalinna Oyj | 311.35M |
| Oriola Oyj | 202.29M |
| Nightingale Health Oyj | 128.10M |
| Nexstim | 103.87M |
| Nanoform Finland Oyj | 91.15M |